Skip to main content
Free research Free research Free compound review with research home and workspace preview
Quick search ChEMBL 36
Compound Detail

CHEMBL4297603

DEUTIVACAFTOR
💊 Approved Drug
Enter ChEMBL ID:
Free Research Context This compound will appear in recent viewed items on the research home for this browser.
Research home View demo workspace
💊 Approved Drug
[2H]C([2H])([2H])C(c1cc(C(C)(C)C)c(NC(=O)c2c[nH]c3ccccc3c2=O)cc1O)(C([2H])([2H])[2H])C([2H])([2H])[2H]
ChEMBL ↗ Properties Compare Identifier

Basic Information

ChEMBL ID CHEMBL4297603
Name DEUTIVACAFTOR
Phase Approved
Structure Type MOL
InChI Key PURKAOJPTOLRMP-ASMGOKTBSA-N
Therapeutic ✓ Yes
Parent Compound CHEMBL2010601
Active Moiety CHEMBL2010601

Known Names

Ctp-656 D9-ivacaftor Deuterated ivacaftor Deutivacaftor Deutivacaftor component of alyftrek Ivacaftor d9 Vx-561
0
Targets
0
Activities
0
Assay Types
0
PK Parameters
0
Publications
7
Known Names
1
Indications
1
Mechanisms

Molecular Properties

392.5
MW (Da)
5.08
ALogP
3
HBA
3
HBD
82.2
PSA (Ų)
0.57
QED
1
Ro5 Violations
2
Rot. Bonds

Drug Information

Molecule Type Small molecule
First Approval 2024
Availability Prescription
Chirality Achiral

Routes of Administration

Oral
USAN Stem -caftor; deu-
USAN Year 2018

Extended Properties

Molecular Formula C24H28N2O3
MW 401.55
Aromatic Rings 3
Heavy Atoms 29
NP-Likeness -0.22

Mechanism of Action

Mechanism Action Type Target Direct Efficacy
Cystic fibrosis transmembrane conductance regulator activator ACTIVATOR Cystic fibrosis transmembrane conductance regulator ✓ ✓

Indications

Cystic Fibrosis

Data from ChEMBL 36 via Core Engine